ESALY

Eisai (PK) (ESALY)

Eisai Company Ltd (PK)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:USOTC:ESALY

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/01/10	01:01	Dow Jones News	Trending: Biogen, Eisai Win FDA Nod for Alzheimer's Drug	USOTC:ESALY	Eisai Company Ltd (PK)
2023/01/07	07:20	Dow Jones News	ADRs End Higher, Shell and Eisai Trade Actively	USOTC:ESALY	Eisai Company Ltd (PK)
2022/12/01	00:46	Dow Jones News	Trending: Eisai/Biogen Alzheimer's Drug Shows Positive Results	USOTC:ESALY	Eisai Company Ltd (PK)
2022/11/30	20:05	TipRanks	Biogen and Eisai’s Alzheimer’s Drug May Pose Serious Risks, Say Researchers	USOTC:ESALY	Eisai Company Ltd (PK)
2022/09/29	02:45	Dow Jones News	Drug Companies Pursuing Alzheimer Treatments See Shares Rise Wednesday	USOTC:ESALY	Eisai Company Ltd (PK)
2022/09/28	11:05	Dow Jones News	Eisai Shares Indicated Sharply Higher After Trial of Experimental Drug Slows Alzheimer's Progression	USOTC:ESALY	Eisai Company Ltd (PK)
2022/08/03	20:48	Dow Jones News	Merck: Two Phase 3 Keytruda Studies Miss Targets	USOTC:ESALY	Eisai Company Ltd (PK)
2022/07/06	12:05	Dow Jones News	Eisai Shares Rise Sharply After U.S. FDA Grants Priority Review for Potential Alzheimer's Drug	USOTC:ESALY	Eisai Company Ltd (PK)
2021/12/23	12:27	Dow Jones News	Eisai Shares Fall Sharply After Japan Panel Seeks More Data for Aduhelm Review	USOTC:ESALY	Eisai Company Ltd (PK)
2021/12/22	22:26	Dow Jones News	Biogen: Japan Panel Seeks Additional Data in Aducanumab Review	USOTC:ESALY	Eisai Company Ltd (PK)
2021/12/17	22:00	Dow Jones News	Biogen's Alzheimer's Treatment Gets Negative CHMP Opinion	USOTC:ESALY	Eisai Company Ltd (PK)
2021/11/29	21:28	Dow Jones News	Merck, Eisai Get Europe OK for Lenvima/Keytruda Combination in Two Cancers	USOTC:ESALY	Eisai Company Ltd (PK)
2021/11/12	08:40	Dow Jones News	Biogen, Eisai Alzheimer Treatment Shows Positive Signs in Advanced Trial	USOTC:ESALY	Eisai Company Ltd (PK)
2021/10/15	21:21	Dow Jones News	Merck, Eisai Get CHMP Backing for Lenvima-Keytruda Combo in Two Cancers	USOTC:ESALY	Eisai Company Ltd (PK)
2016/01/29	07:00	Dow Jones News	FDA Approves Eisai's Halaven to Treat Liposarcoma	USOTC:ESALY	Eisai Company Ltd (PK)
2015/09/02	15:00	Dow Jones News	Amgen to Help Develop Novartis's Pipeline of Alzheimer's Drugs	USOTC:ESALY	Eisai Company Ltd (PK)
2015/06/10	00:06	The Motley Fool	Obesity Drugs: Stocks to Watch	USOTC:ESALY	Eisai Company Ltd (PK)
2015/04/10	08:20	Dow Jones News	Japanese Drug Company Eisai to Cut 25% of U.S. Jobs	USOTC:ESALY	Eisai Company Ltd (PK)
2015/03/29	01:03	The Motley Fool	5 Freakishly Expensive Cancer Drugs	USOTC:ESALY	Eisai Company Ltd (PK)
2014/09/11	21:50	Dow Jones News	FDA Approves Orexigen's Diet Drug Contrave	USOTC:ESALY	Eisai Company Ltd (PK)
2013/12/17	07:05	Zacks	Pipeline Progress at Corcept - Analyst Blog	USOTC:ESALY	Eisai Company Ltd (PK)
2013/11/09	07:00	Zacks	Arena Pharma Q3 Loss Narrower than Expected - Analyst Blog	USOTC:ESALY	Eisai Company Ltd (PK)
2013/06/17	11:53	Dow Jones News	ASIA MARKETS: Japan Stocks Rebound As Asia Awaits Fed Meeting	USOTC:ESALY	Eisai Company Ltd (PK)
2013/05/14	19:02	Zacks	Jazz Pharma Posts Higher Y/Y Earnings - Analyst Blog	USOTC:ESALY	Eisai Company Ltd (PK)
2013/05/06	20:10	Zacks	Arena Pharma Narrows Loss - Analyst Blog	USOTC:ESALY	Eisai Company Ltd (PK)
2013/04/24	02:45	Zacks	Data from Novartis' SPARK - Analyst Blog	USOTC:ESALY	Eisai Company Ltd (PK)
2013/04/17	03:30	Zacks	BioLineRx to Start BL-8040 Study - Analyst Blog	USOTC:ESALY	Eisai Company Ltd (PK)
2013/04/17	03:30	Zacks	BioLineRx to Start BL-8040 Study - Analyst Blog	USOTC:ESALY	Eisai Company Ltd (PK)
2013/04/10	02:55	Zacks	Patients Dosed in Arena Study - Analyst Blog	USOTC:ESALY	Eisai Company Ltd (PK)
2013/03/08	23:43	Zacks	Arena Cuts Loss, Misses Estimates - Analyst Blog	USOTC:ESALY	Eisai Company Ltd (PK)